Patients with systemic inflammatory COPD show higher BNIP3- and BNIP3L-mediated mitophagy marker levels than those with normal COPD, which suggests that BNIP3-mediated mitophagy might promote systemic COPD inflammation (Leermakers et al., 2018). Here, BNIP3L is linked to chronic obstructive pulmonary disease.